Systems and methods for application of fMRI as a biomarker of neural abnormalities are presented. A subject's activations of brain regions that occur while performing cognitive tasks in an fMRI scanning apparatus are measured. The resulting measurements are compared to the activations of brain regions that occur during each cognitive task for a control group. The comparison to the performance and brain activations of normal subjects determine the presence of cortical compensatory mechanisms that indicate neural abnormalities in the subject.
FUNCTIONAL MAGNETIC RESONANCE IMAGING BIOMARKER OF NEURAL ABNORMALITY